Mitochondria as a target of cardioprotection in models of preconditioning
- 20 July 2017
- journal article
- review article
- Published by Springer Nature in Journal of Bioenergetics and Biomembranes
- Vol. 49 (5) , 357-368
Abstract
Over the recent years the view on mitochondria in the heart as a cellular powerhouse providing ATP supply needed to sustain contractile function, basal metabolic processes, and ionic homeostasis has changed radically. At present it is known that dysfunctions of these organelles are essential in the development of a large number of diseases, including cardiovascular diseases. Moreover, mitochondria are considered to be a very promising target of endogenous strategies that are essential in the protection of the myocardium from acute ischemia/reperfusion injury. These strategies including ischemic preconditioning, remote ischemic preconditioning as well as the acute phase of streptozotocin-induced diabetes mellitus, provide a similar effect of protection. Alterations observed in the functional and structural properties of heart mitochondria caused by short-term pathological impulses are associated with endogenous cardioprotective processes. It seems that the extent of mitochondrial membrane fluidization could be an active response mechanism to injury with a subtle effect on membrane-associated processes which further affect the environment of the whole organelle, thus inducing metabolic changes in the heart. In this review article, we provide an overview of endogenous protective mechanisms induced by hypoxic, pseudohypoxic and ischemic conditions with special consideration of the role of heart mitochondria in these processes.Keywords
Funding Information
- Agentúra na Podporu Výskumu a Vývoja (15-0119, 15-0607)
- Vedecká Grantová Agentúra MŠVVaŠ SR a SAV (2/0133/15, 2/0201/15)
- Structural Funds and Cohesion Fund (26230120006)
This publication has 137 references indexed in Scilit:
- Targeting hexokinase II to mitochondria to modulate energy metabolism and reduce ischaemia‐reperfusion injury in heartBritish Journal of Pharmacology, 2014
- The use of animal models in diabetes researchBritish Journal of Pharmacology, 2012
- Intracellular Shuttle: The Lactate Aerobic MetabolismThe Scientific World Journal, 2012
- Is hyperglycemia bad for the heart during acute ischemia?The Journal of Thoracic and Cardiovascular Surgery, 2010
- Consecutive pharmacological activation of PKA and PKC mimics the potent cardioprotection of temperature preconditioningCardiovascular Research, 2010
- Substrate–Enzyme Competition Attenuates Upregulated Anaplerotic Flux Through Malic Enzyme in Hypertrophied Rat Heart and Restores Triacylglyceride ContentCirculation Research, 2009
- Cholesterol, Reactive Oxygen Species, and the Formation of Biologically Active MediatorsJournal of Biological Chemistry, 2008
- Glucose Phosphorylation and Mitochondrial Binding Are Required for the Protective Effects of Hexokinases I and IIMolecular and Cellular Biology, 2008
- The role of mitochondria in protection of the heart by preconditioningBiochimica et Biophysica Acta (BBA) - Bioenergetics, 2007
- Regulation of fatty acid oxidation in the mammalian heart in health and diseaseBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1994